People

Olga Morozova, PhD

Olga (Olya) Morozova is an Assistant Professor of Public Health Sciences. She is an infectious disease epidemiologist and a public health modeler. Her research focuses on interaction between HIV and substance use disorders, as well as infectious disease transmission more broadly. Dr. Morozova conducted studies to evaluate strategies to expand access to and uptake of opioid agonist treatment in Ukraine. She piloted studies of primary healthcare-based integrated care for people with opioid use disorder in Ukraine and conducted model-based policy and cost-effectiveness evaluation of treatment scale-up strategies. Dr. Morozova's COVID-19 modeling work during the pandemic involved novel methods to incorporate behavior change metrics in traditional infection transmission modeling. Results of her modeling work were used to support decision-makers at Connecticut's governor’s office. Dr. Morozova is also interested in quantitative methods in infectious disease epidemiology, in particular causal inference in the presence of contagion. Her work contributed to a better understanding of the properties of traditional vaccine effect estimates under various study designs.

Yale University
New Haven, CT, USA
Ph.D. - Epidemiology
2018

Kyiv National University
Kyiv, Ukraine
M.S. - Mathematical Modeling in Social Sciences
2005

Kyiv National University
Kyiv, Ukraine
B.S. - Applied Mathematics
2003

Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine.
Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine. Contemp Clin Trials. 2024 Sep 14; 146:107690.
PMID: 39265780

"Will you need this health at all? Will you be alive?": using the bioecological model of mass trauma to understand HIV care experiences during the war in Ukraine.
"Will you need this health at all? Will you be alive?": using the bioecological model of mass trauma to understand HIV care experiences during the war in Ukraine. J Int AIDS Soc. 2024 Jul; 27 Suppl 3:e26307.
PMID: 39030874

Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers.
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers. J Int AIDS Soc. 2024 Jul; 27 Suppl 3:e26319.
PMID: 39030884

Modes of HIV transmission among young women and their sexual partners in Ukraine.
Modes of HIV transmission among young women and their sexual partners in Ukraine. PLoS One. 2024; 19(6):e0305072.
PMID: 38923979

Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine.
Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine. Int J Drug Policy. 2024 Jan; 123:104284.
PMID: 38061223

ASSESSMENT AND CHARACTERIZATION OF COVID-19 RELATED COGNITIVE DECLINE: RESULTS FROM A NATURAL EXPERIMENT.
ASSESSMENT AND CHARACTERIZATION OF COVID-19 RELATED COGNITIVE DECLINE: RESULTS FROM A NATURAL EXPERIMENT. medRxiv. 2023 Nov 07.
PMID: 37986906

Design, implementation and preliminary results of a type-2 hybrid cluster-randomized trial of integrating screening and treatment for major depressive disorder into specialty clinics providing opioid agonist therapies in Ukraine.
Design, implementation and preliminary results of a type-2 hybrid cluster-randomized trial of integrating screening and treatment for major depressive disorder into specialty clinics providing opioid agonist therapies in Ukraine. Contemp Clin Trials. 2023 08; 131:107248.
PMID: 37263492

Treatment of opioid use disorder in Ukraine during the first year of the Russia-Ukraine war: Lessons learned from the crisis.
Treatment of opioid use disorder in Ukraine during the first year of the Russia-Ukraine war: Lessons learned from the crisis. Int J Drug Policy. 2023 Jul; 117:104062.
PMID: 37216758

Polygenic risk scores for asthma and allergic disease associate with COVID-19 severity in 9/11 responders.
Polygenic risk scores for asthma and allergic disease associate with COVID-19 severity in 9/11 responders. PLoS One. 2023; 18(3):e0282271.
PMID: 36893177

Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial.
Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial. PLOS Glob Public Health. 2022; 2(11):e0000344.
PMID: 36962514

View All Publications